NCT05469282

CEFID-I (CEra Flow Improves DVT-1)

A Single Center Clinical Trial to Evaluate the Efficacy and Safety of Blood Circulation Improvement Using an Investigational Medical Device (Model Name CGM MB-1701) for the Risk Group of Deep Vein Thrombosis (DVT) and the Ordinary Person

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 59 (actual)
• Sponsor: Ceragem Clinical Inc. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The study is a single center clinical trial to evaluate the efficacy and safety of blood circulation improvement using an investigational medical device, which is a product on the market and it's name is Ceragem Master V6, for the risk group of Deep Vein Thrombosis (DVT) and the ordinary person. The study compares before and after the application by one time application.

Detailed description

The efficacy and safety evaluation are conducted before and after (or during) the application of the test device. The investigator shall apply an investigational device once when visiting a suitable subject for one day.

Conditions

• Blood Circulation Disorder
• Deep Vein Thrombosis

Interventions

Type	Name	Description
DEVICE	Blood circulation device	Blood circulation device of CGM MB-1701 (Ceragem Master V6)

Timeline

• Start date: 2022-08-22
• Primary completion: 2022-12-30
• Completion: 2022-12-30
• First posted: 2022-07-21
• Last updated: 2026-02-09

Locations

1 site across 1 country: South Korea